子宫内避孕器市场规模、份额和成长分析（按类型、年龄层和地区）：产业预测（2024-2031）

2022年全球子宫内避孕器市场规模估值为31.2亿美元，从2023年的32.3亿美元成长到2031年的43.6亿美元，预测期（2024-2031年）复合年增长率预计将成长3.8%。

由于意外怀孕、不安全堕胎率上升以及人们对避孕选择的认识不断增强，子宫内避孕器 (IUD) 市场正在显着增长。为了满足这项需求，政府的措施和研发进步正在推动创新子宫内避孕器的诞生。在美国，随着政府努力改善获得性健康和生殖健康服务的机会，计划晚孕的趋势补充了这一增长趋势。然而，缺乏对子宫内避孕器的认识、潜在的副作用以及过早取出等挑战正在阻碍市场的扩张。儘管存在这些障碍，新兴经济体可支配收入的增加和对健康生活方式不断增长的需求为市场相关人员提供了充满希望的机会。持续的技术创新和监管支援预计将进一步推动市场成长。

目录

介绍

• 分析目的
• 市场范围
• 定义

分析方法

• 资讯采购
• 次要/主要资料方法
• 市场规模预测
• 市场假设与约束

执行摘要

• 市场概况及展望
• 供需趋势分析
• 按细分市场的机会分析

市场动态及前景

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 抑制因素和挑战
• 波特分析与影响
  • 竞争公司之间的敌对关係
  • 替代品的威胁
  • 买方议价能力
  • 新进入者的威胁
  • 供应商的议价能力

主要市场考虑因素

• 关键成功因素
• 竞争程度
• 主要投资来源
• 市场生态系统
• 市场魅力指数（2023）
• PESTEL分析
• 总体经济指标
• 价值链分析
• 价格分析
• 技术进步
• 监管环境
• 案例研究

全球子宫内避孕器市场规模和复合年增长率：按类型（2024-2031）

• 非荷尔蒙：含铜子宫内避孕器
• 荷尔蒙：释放黄体素的子宫内避孕器

全球子宫内避孕器市场规模与复合年增长率：按年龄组别划分（2024-2031）

• 25-34岁
• 35-44岁
• 44岁以上
• 15-24岁

全球子宫内避孕器市场规模及复合年增长率：按分销管道划分（2024-2031）

• 医院
• 妇科门诊
• 社区健康服务中心
• 其他的

全球子宫内避孕器市场规模和复合年增长率：按最终用户划分（2024-2031）

• 医院
• 诊所
• 区域医疗中心
• 其他的

全球子宫内避孕器市场规模及复合年增长率（2024-2031）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 英国
  • 德国
  • 西班牙
  • 法国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东/非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东/非洲

竞争格局

• 前5名企业对比
• 主要企业市场定位（2023年）
• 主要企业采取的策略
• 近期市场趋势
• 主要企业市场占有率（2023年）
• 主要企业简介
  • 公司简介
  • 产品系列分析
  • 按细分市场分類的份额分析
  • 收益与前一年同期比较（2021-2023）

主要企业简介

• AbbVie Inc.
• Bayer AG
• CooperSurgical Inc.
• DKT International
• EUROGINE, SL
• Mona Lisa NV
• OCON Medical Ltd.
• Pregna International Limited.
• Prosan International BV
• SMB Corporation of India
• Teva Pharmaceuticals
• ANI Pharmaceuticals
• Mylan NV (Viatris)
• Melbea AG
• Contrel Europe
• Durbin
• Gima SpA
• HLL Lifecare Limited
• Meril Life Sciences Pvt. Ltd
• Mona Lisa NV

结论和建议

Global Intrauterine Devices Market size was valued at USD 3.12 billion in 2022 and is poised to grow from USD 3.23 billion in 2023 to USD 4.36 billion by 2031, growing at a CAGR of 3.8% during the forecast period (2024-2031).

The intrauterine devices (IUD) market is witnessing significant growth driven by increasing rates of unplanned pregnancies, unsafe abortions, and heightened awareness of contraceptive options. To support this demand, government initiatives and advancements in research and development are fostering the creation of innovative IUDs. In the U.S., the trend towards planned delayed pregnancies complements this upward trajectory, as the government promotes better access to sexual and reproductive health services. However, challenges such as insufficient awareness of IUDs, potential side effects, and early removals hinder market expansion. Despite these obstacles, emerging economies are showing promising opportunities for market players due to rising disposable incomes and a growing demand for healthy lifestyles. Continued innovations and regulatory support are anticipated to further propel market growth.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Intrauterine Devices market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Intrauterine Devices Market Segmental Analysis

Global Intrauterine Devices Market is segmented by Type, by Age Group, by Distribution Channel, by End User and by Region. Based on Type, the market is segmented into Nonhormonal: Copper-containing IUD, Hormonal: Progestogen-releasing. Based on Age Group, the market is segmented into 25-34 years, 35-44 years, Above 44 years, 15-24 years. Based on Distribution Channel, the market is segmented into Hospital, Gynecology Clinics, Community Health Care Centers, and Others. Based on End User, the market is segmented into Hospitals, Clinics, Community Health Care Centres, Others. Based on Region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East and Africa.

Driver of the Global Intrauterine Devices Market

The global intrauterine devices market is significantly driven by the rising awareness and acceptance of contraception. As public understanding of family planning's importance grows, so does the recognition of effective contraceptive methods, particularly long-term solutions like intrauterine devices (IUDs). This heightened awareness among individuals and healthcare professionals regarding the advantages of IUDs has led to an increased demand for these devices. Consequently, the emphasis on effective birth control options is propelling the market forward, reflecting a broader trend in society towards informed reproductive health choices and greater accessibility to reliable contraceptive methods.

Restraints in the Global Intrauterine Devices Market

The Global Intrauterine Devices market faces significant constraints due to stringent regulatory requirements. As medical devices, intrauterine devices must adhere to rigorous safety and effectiveness standards imposed by regulatory authorities. This landscape can create considerable challenges for manufacturers, making it difficult for them to meet compliance benchmarks, secure necessary approvals, and navigate the complex regulatory environment. Consequently, these stringent regulations may deter new entrants from entering the market, ultimately restricting the growth potential of the intrauterine devices sector. As a result, the combination of regulatory hurdles and compliance demands presents a notable obstacle to market expansion.

Market Trends of the Global Intrauterine Devices Market

The global Intrauterine Devices (IUDs) market is experiencing significant growth, driven by the rising incidence of unplanned pregnancies and increasing acceptance of IUDs as effective contraceptive options. Hormonal IUDs are gaining popularity, not only for their contraceptive benefits but also for their ability to manage menstrual issues, including severe cramps and heavy bleeding. Awareness initiatives by health organizations are further enhancing consumer education on family planning and the negative health impacts of unintended pregnancies. Moreover, the expanding demographic appeal of IUDs to nulliparous women and adolescents underscores a shift in contraceptive preferences, positioning the market for substantial long-term expansion.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Driver & Opportunities
  • Restraints & Challenges
• Porters Analysis & Impact
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2023
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Technological Advancement
• Regulatory Landscape
• Case Studies

Global Intrauterine Devices Market Size by Type & CAGR (2024-2031)

• Nonhormonal: Copper-containing IUD
• Hormonal: Progestogen-releasing IUD

Global Intrauterine Devices Market Size by Age Group & CAGR (2024-2031)

• 25-34 years
• 35-44 years
• Above 44 years
• 15-24 years

Global Intrauterine Devices Market Size by Distribution Channel & CAGR (2024-2031)

• Hospital
• Gynecology Clinics
• Community Health Care Centers
• Others

Global Intrauterine Devices Market Size by End User & CAGR (2024-2031)

• Hospitals
• Clinics
• Community Health Care Centres
• Others

Global Intrauterine Devices Market Size by Region & CAGR (2024-2031)

• North America, (by Type, by Age Group, by Distribution Channel, by End User)
  • US
  • Canada
• Europe, (by Type, by Age Group, by Distribution Channel, by End User)
  • UK
  • Germany
  • Spain
  • France
  • Italy
  • Rest of Europe
• Asia-Pacific, (by Type, by Age Group, by Distribution Channel, by End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia Pacific
• Latin America, (by Type, by Age Group, by Distribution Channel, by End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa, (by Type, by Age Group, by Distribution Channel, by End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2023
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2021-2023)

Key Company Profiles

• AbbVie Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CooperSurgical Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DKT International
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• EUROGINE, S.L.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• OCON Medical Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pregna International Limited.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prosan International BV
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SMB Corporation of India
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teva Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ANI Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mylan NV (Viatris)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Melbea AG
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contrel Europe
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Durbin
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Gima S.p.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HLL Lifecare Limited
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences Pvt. Ltd
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mona Lisa N.V.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendation